D-Galactose

CAT:
804-HY-N0210-01
Size:
100 mg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
D-Galactose - image 1

D-Galactose

  • UNSPSC Description:

    D-Galactose is a natural aldohexose and C-4 epimer of glucose.
  • Target Antigen:

    Endogenous Metabolite
  • Type:

    Natural Products
  • Related Pathways:

    Metabolic Enzyme/Protease
  • Applications:

    Neuroscience-Neuromodulation
  • Field of Research:

    Neurological Disease
  • Assay Protocol:

    https://www.medchemexpress.com/D-Galactose.html
  • Purity:

    98.0
  • Solubility:

    DMSO : 50 mg/mL (ultrasonic)|H2O : 62.5 mg/mL (ultrasonic;warming;heat to 60°C)
  • Smiles:

    O=C[C@@H]([C@H]([C@H]([C@@H](CO)O)O)O)O
  • Molecular Weight:

    180.16
  • References & Citations:

    [1]Csiszovszki Z, et al. Structure and function of the D-galactose network in enterobacteria. MBio. 2011 Jun 28;2(4):e00053-11.|[2]Cui X, et al. Chronic systemic D-galactose exposure induces memory loss, neurodegeneration, and oxidativedamage in mice: protective effects of R-alpha-lipoic acid. J Neurosci Res. 2006 Aug 15;84(3):647-54.|[3]Budni J, et al. Oral administration of d-galactose induces cognitive impairments and oxidative damage in rats. Behav Brain Res. 2016 Apr 1;302:35-43.|[4]Haifeng Wei, et al. Behavioural study of the Haifeng Wei, et al. Behavioural study of the D-galactose induced aging model in C57BL/6J mice. Behav Brain Res. 2005, 157, 22.|[5]Saida Haider, et al. A high dose of short term exogenous D-galactose administration in young male rats produces symptoms simulating the natural aging process. Life Sci. 2015.|[6]Wenjing Feng, et al. Alginate Oligosaccharide Prevents against D-galactose-mediated Cataract in C57BL/6J Mice via Regulating Oxidative Stress and Antioxidant System. Curr Eye Res. 2021, 46, 6.|[7]Lei Zhong, et al. Characterization of an i.p. D-galactose-induced cataract model in rats. J Pharmacol Toxicol Methods. 2021.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Clinical Information:

    Phase 2
  • CAS Number:

    59-23-4